Jennifer M. Pugliese, Richard N. Greene, Andrew C. Peterson

Canadian Journal of Urology, Vol.16, No.6, pp. 4927-4931, 2009

Abstract Purpose: We examined patterns of intravesical therapy use in nonmuscle invasive bladder cancer over the last 10 years at our institution where there is equal access to healthcare. We further examined any affect that the introduction of national guidelines may have had on the utilization of intravesical therapy in these patients.
Materials and methods: An Institutional Review Board (IRB) approved retrospective chart review was performed between the years 1997 and 2007. Only those with premalignant or malignant pathology, as identified using intradepartmental surgical logs and pathology reports, were included.
Results: Four hundred seventeen procedures, representing 228 patients, were… More >

Canadian Journal of Urology, Vol.13, Suppl.3, pp. 62-64, 2006

Abstract Wait times for medical procedures in Canada continue to be a major issue in the delivery of timely health care. Patients scheduled to undergo surgery for urological malignancies, which include prostate, bladder, kidney and testes cancer, are among the many affected populations. To address these important issues, a Surgical Wait Time (SWAT) initiative was undertaken. The SWAT initiative, whose members consist of urological oncologists, surgeons and methodologists was mandated to assess current wait times in Canada, review the relevant literature on the surgical wait times for urological cancers and then develop a consensus document that More >

Jacques Corcos¹, Jerzy Gajewski², Diane Heritz³, Allan Patrick⁴, Ian Reid⁵, Erik Schick⁶, Lynn Stothers⁷

Canadian Journal of Urology, Vol.13, No.3, pp. 3127-3138, 2006

Abstract Objective: To develop the first Canadian guidelines for the management of adult urinary incontinence (UI).
Method: Following a mandate of the Canadian Urological Association, six Canadian urologists collaborated to produce these guidelines after having extensively reviewed existing foreign guidelines and literature from 1966 to June 2005.
Results: The terminology proposed by the standardization committee of the International Continence Society (ICS) is recommended. Basic evaluation must include a history, physical examination, evaluation of post void residual volume, urinalysis and voiding diary. A more detailed evaluation is recommended for complex cases or if initial management fails. As non-pharmacological treatments,… More >

Bertil F. M. Blok, Gilles Karsenty, Jacques Corcos

Canadian Journal of Urology, Vol.13, No.5, pp. 3239-3243, 2006

Abstract Objective: To determine current trends in management and surveillance of the neurogenic bladder population by Canadian urologists who routinely work with and provide care for these patients.
Methods: A questionnaire was mailed to members of the Canadian Urological Association. The assessment and follow-up of upper and lower urinary tract function in neurogenic bladder patients, their optimal frequency and management of related infections were the topics of inquiry.
Results: One hundred and five of 602 urologists responded, for a response rate of 18%. Twenty-three (22%) of the respondents did not treat neurogenic bladder patients. Four out of five… More >

J. Curtis Nickel¹, Sender Herschorn², Jacques Corcos², Bryan Donnelly¹, Doug Drover², Mostafa Elhilali¹, Larry Goldenberg¹, John Grantmyre², Bruno Laroche², Richard Norman¹, Bruce Piercy¹, Karen Psooy², Gary Steinhoff¹, John Trachtenberg¹, Fred Saad¹, Simon Tanguay¹

Canadian Journal of Urology, Vol.12, No.3, pp. 2677-2683, 2005

Abstract Objective: To develop the first Canadian guidelines for the management of lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
Methods: These guidelines, developed under a mandate provided by the Canadian Urological Association (CUA), were a collaborative effort between the CUA guidelines committee and the Canadian Prostate Health Council. BPH guidelines developed by the American Urological Association, the European Association of Urology, the World Health Organization International Consultation on BPH, and similar committees from Germany, Sweden and Australia were reviewed. The committee further reviewed a systematic literature search, updated to May 2004, and systematically derived… More >

J. Curtis Nickel¹, Fred Saad²

Canadian Journal of Urology, Vol.11, No.2, pp. 2186-2193, 2004

Abstract The 2003 American Urological Association (AUA) guideline on management of benign prostatic hyperplasia (BPH) was released at the AUA annual meeting in Chicago, April 2003 and the diagnosis and treatment recommendations were published later in 2003. It is likely that the 2003 AUA guideline on the management of BPH will have a profound effect on clinical urologic practice in the USA, but its influence on Canadian urological practice will be different because of our socialized medical system, manpower issues, availability of expensive technology and our unique Canadian perspective. The authors review the 2003 AUA guideline More >

Laurence H. Klotz

Canadian Journal of Urology, Vol.9, No.5, pp. 1623-1623, 2002

Abstract This article has no abstract. More >

Canadian Urological Association Guidelines Committee

Canadian Journal of Urology, Vol.9, No.4, pp. 1583-1587, 2002

Abstract Erectile dysfunction has undergone dramatic advances in diagnosis and therapeutics over the past decade. Increasing numbers of men are currently seeking medical help for their sexual concerns, often from primary health care providers.
The Canadian Urological Association (CUA), Guidelines Committee is charged with the responsibility of creating practice guidelines for urologic conditions with the goal of improving physician knowledge and enhancing patient care. These Erectile Dysfunction Guidelines highlight the evolving use of a minimally invasive patient self­directed goal oriented approach to evaluation and treatment using oral agents as first-line therapy based on efficacy, side effect More >